Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

A medicine for treating cardiovascular and cerebrovascular disease

A technology for cardiovascular and cerebrovascular diseases and drugs, applied in the field of drugs composed of effective parts, can solve the problems of clinical drug safety hazards, large doses of patients taking, toxic and side effects, etc., and achieve the reduction of ischemia-reperfusion injury, clear active ingredients, and toxicity. Effect with low side effects

Active Publication Date: 2006-12-20
CHENGDU YILUKANG MEDICAL TECH & SERVICE
View PDF0 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0009] Some new varieties of drugs for the treatment of cardiovascular and cerebrovascular diseases developed and marketed abroad in the 1990s cannot be imitated and produced at will in China because they involve the protection of invention patents of foreign companies, so they can only rely on imports to meet domestic clinical urgent needs
[0010] At the same time, the above drugs often have the following toxic and side effects: slow heart rate, fatigue, dry mouth, chest tightness, etc., often accompanied by abnormal phenomena such as headache, facial flushing, ankle edema, etc. Some drugs can even cause liver damage and muscle dissolution, etc. serious side effects
[0011] The existing Western medicines for the treatment of cardiovascular and cerebrovascular diseases have various side effects. Traditional Chinese medicines are more and more concerned by medical researchers and patients because of their significant curative effect, stability and reliability, and small toxic and side effects. However, most of the existing Chinese medicines are multi-flavor The medicinal material formula is made, because it is a crude extract, the onset of effect is slow, and the patient takes a large amount, which leads to a large waste of medicinal material resources, and the active ingredients are not clear, and the quality of the drug cannot be strictly controlled. cause safety hazard

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0047] Take 10 g of acetaloflavones, 1 g of total saponins of Panax notoginseng, and 25 g of vegetable oil, mix them evenly, use gelatin as the capsule shell material, and press them into soft capsules to obtain a soft capsule dosage form containing 1 part of acetaloflavones and 0.1 part of total saponins of notoginseng medicine.

Embodiment 2

[0049] Take 1 g of acetaloflavone and 20 g of total saponins of Panax notoginseng, dissolve them in 1000 ml of water for injection, and adopt the existing powder injection preparation process to obtain a medicine in powder injection form containing 1 part of acetaloflavone and 20 parts of total saponins of notoginseng.

Embodiment 3

[0051] Get 5 g of acetaloflavone, 5 g of total saponins of Panax notoginseng, and 90 g of starch, mix them evenly, and adopt a capsule preparation process to obtain a medicine in the form of a hard capsule containing 1 part of acetaloflavone and 1 part of total saponins of Panax notoginseng.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a medicament for treating cardiovascular and cerebrovascular diseases, wherein the raw material includes the constituents of hippophe flavone 1 part, Notoginsen triterpenes 0.1-20 parts.

Description

Technical field [0001] The invention relates to a medicine for treating cardiovascular and cerebrovascular diseases, specifically the medicine composed of effective parts of sea buckthorn and notoginseng. Background technique [0002] Cardiovascular and cerebrovascular diseases such as coronary heart disease, cerebral infarction, and cerebral apoplexy are common diseases that seriously endanger human life and health. According to the report of the World Health Organization, 1 of every 3 deaths in the United States is caused by cardiovascular and cerebrovascular diseases. More than half a million people died of myocardial infarction. Cardiovascular and cerebrovascular diseases have become the number one killer of human health, and their morbidity and mortality have surpassed those of tumor diseases and rank first. Most patients need to take medicine for life. Statistics show that the world's cardiovascular and cerebrovascular drug market sales in 2000 were nearly 50 billion ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K31/704A61K36/258A61K9/00A61P9/10
Inventor 罗蜀蓉林辉
Owner CHENGDU YILUKANG MEDICAL TECH & SERVICE
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com